✦ LIBER ✦

Relative sensitivity of the endogenous hprt gene and lacl transgene in ENU-treated big blue™ B6C3F1 mice

✍ Scribed by Thomas R. Skopek; Kristy L. Kort; Deborah R. Marino

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 653 KB
Volume: 26
Category: Article
ISSN: 0893-6692
DOI: 10.1002/em.2850260103

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

System Issues: Mutagenic response of the

System Issues: Mutagenic response of the endogenous hprt gene and lacl transgene in benzo[a]pyrene-treated Big Blue™ B6C3F1 mice

✍ Thomas R. Skopek; Kristy L. Kort; Deborah R. Marino; Lakshmi V. Mittal; Diane R. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 807 KB

Big Blue@ (BB) and generic B6C3F1 mice were given one to three i.p. injections of 50 mg/kg benzo[a]pyrene (B[a]P) in DMSO every other day to achieve cumulative doses of 50 to 150 mg/kg. Three weeks after treatment, the mutation frequency at the endogenous hprt gene and lac/ transgene was measured in

Transmission of mutations in the lacI tr

Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue® male mice

✍ Lois B. Barnett; Rochelle W. Tyl; Barbara S. Shane; Michael D. Shelby; Susan E. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Mutational specificity: Assessment of 1,

Mutational specificity: Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacl transgenic mice (Big Blue®): A review of mutational spectrum and LACL mutant frequency after a 5-day 625 PPM 1,3-butadiene exposure

✍ Leslie Recio; Kathy G. Meyer; Linda J. Pluta; Owen R. Moss; Christopher J. Saran 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Carolina 1,3-Butadiene (BD) is a carcinogen that is bioactivated to at least two genotoxic metabolites. In the present article, we review briefly our previous studies on the in vivo mutagenicity and mutational spectra of BD in bone marrow and extend these studies to examine the effect of exposure ti